19338005: 2 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module

3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
2	Is a	General adjectival modifier	false	Inferred relationship	Existential restriction modifier
2	Is a	Number	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely ampicillin (as ampicillin trihydrate) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline (as nortriptyline hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline (as nortriptyline hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely levothyroxine sodium anhydrous 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only articaine and epinephrine (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only enalapril and felodipine in oral dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only lanolin and zinc oxide (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only cetirizine and pseudoephedrine (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only articaine and epinephrine in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only morphine and naltrexone (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only benzocaine and trimethobenzamide in rectal dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only benzocaine and trimethobenzamide (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only prednisolone and sulfacetamide in ocular dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only lanolin and zinc oxide in cutaneous dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only prednisolone and sulfacetamide (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only boric acid and salicylic acid (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only carmellose and durapatite (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only citric acid and potassium bicarbonate in oral dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only boric acid and salicylic acid in cutaneous dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only carmellose and durapatite in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only citric acid and potassium bicarbonate (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only morphine and naltrexone in oral dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only fluorescein stain and oxybuprocaine (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only enalapril and felodipine (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only fluorescein stain and oxybuprocaine in ocular dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely nicotinic acid 1 gram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely risperidone 2 milligram/1 each conventional release orodispersible tablet (clinical drug)	Has presentation strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1
Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1
Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely melatonin 2 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1
Product containing only fluorometholone and sulfacetamide (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely glyceryl trinitrate 2 milligram/1 each conventional release buccal tablet (clinical drug)	Has presentation strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbinoxamine maleate 4 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely belladonna alkaloid 16.2 milligram and opium 30 milligram/1 each conventional release rectal suppository (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely hydrochlorothiazide 12.5 milligram and losartan potassium 100 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only fluorometholone and sulfacetamide in ocular dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely loteprednol etabonate 2 milligram/1 milliliter conventional release eye suspension (clinical drug)	Has concentration strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1
Product containing only benserazide and levodopa in oral dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 2.5 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength numerator value	False	2	Inferred relationship	Existential restriction modifier	2
Product containing precisely cyclopentolate hydrochloride 2 milligram/1 milliliter and phenylephrine hydrochloride 10 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely nicotinic acid 750 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely prednisolone acetate 2 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug)	Has presentation strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only polythiazide and prazosin in oral dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only polythiazide and prazosin (medicinal product)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely prednisolone acetate 2.5 milligram/1 gram and sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely belladonna alkaloid 16.2 milligram and opium 60 milligram/1 each conventional release rectal suppository (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely fluorometholone 1 milligram/1 milliliter and sulfacetamide sodium 100 milligram/1 milliliter conventional release eye suspension (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely dexamethasone 500 microgram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Saxagliptin + Metformin	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 1 gram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing only metformin and saxagliptin in oral dose form (medicinal product form)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely hydrocortisone valerate 2 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Has concentration strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1
Product containing precisely naphazoline hydrochloride 250 microgram/1 milliliter and pheniramine maleate 3 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely cetrimide 1.5 milligram/1 milliliter and chlorhexidine gluconate 150 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely coal tar 50 milligram/1 gram and pine tar 50 milligram/1 gram conventional release cutaneous gel (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely olopatadine (as olopatadine hydrochloride) 2 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1
Product containing precisely glyceryl trinitrate 2 milligram/1 each prolonged-release buccal tablet (clinical drug)	Has presentation strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1
Product containing precisely methylphenidate hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1
Product containing precisely ciprofloxacin 2 milligram/1 milliliter conventional release ear solution (clinical drug)	Has concentration strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1
Product containing precisely esterified estrogen 1.25 milligram and methyltestosterone 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely diiodohydroxyquinoline 10 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely coal tar 60 milligram/1 milliliter and lecithin 4 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely hydrocortisone valerate 2 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Has concentration strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1
Product containing precisely benzalkonium 2.5 milligram/1 gram and polyethylene 219 milligram/1 gram conventional release cutaneous gel (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely lactic acid 250 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely mequinol 20 milligram/1 milliliter and tretinoin 100 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely cetrimide 22.5 milligram/1 milliliter and chlorhexidine gluconate 2.25 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter and dexamethasone 1 milligram/1 milliliter conventional release ear suspension (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous spray (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely acetic acid 20 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear solution (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely cetrimide 5 milligram/1 milliliter and chlorhexidine gluconate (as chlorhexidine) 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	2	Inferred relationship	Existential restriction modifier
Product containing precisely nitrofural 2 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has concentration strength numerator value	False	2	Inferred relationship	Existential restriction modifier	1

Start Previous Page 20 of 35 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
32597014	Two	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3442102012	2 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3442103019	2	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module